Cytosorb Therapy in Cardiac Surgery

CompletedOBSERVATIONAL
Enrollment

249

Participants

Timeline

Start Date

October 18, 2019

Primary Completion Date

December 4, 2019

Study Completion Date

December 4, 2019

Conditions
Cardiopulmonary SurgeryEndocarditisPeri-operative Cytokines Levels
Interventions
DEVICE

CytoSorb haemoadsorption (HA) device

CytoSorb® cartridges contain biocompatible sorbent polystyrene divinylbenzene beads coated with polyvinylpyrrolidone, capable of removing inflammatory molecules (eg Interleukin). The cartridge is inserted in a cardio-pulmonary bypass circuit to remove inflammatory molecules during cardiac surgery .

Trial Locations (1)

4031

Klinik für Herzchirurgie, Universitätsspital Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT04309591 - Cytosorb Therapy in Cardiac Surgery | Biotech Hunter | Biotech Hunter